Literature DB >> 2231924

Nephron-sparing surgery for renal cell carcinoma with venous involvement.

K W Angermeier1, A C Novick, S B Streem, J E Montie.   

Abstract

A nephron-sparing operation recently has been shown to provide extended survival free of disease in selected patients with localized renal cell carcinoma, particularly for tumors of lower stage. To define better the role of conservative surgical treatment in more locally advanced renal cell carcinoma we reviewed 9 patients with venous tumor involvement in solitary functioning kidneys who underwent a nephron-sparing operation. Complete tumor resection with adequate preservation of renal function was accomplished in all cases. Of the 9 patients 5 had no evidence of disease 7 to 93 months (mean 33.2 months) postoperatively. The remaining 4 patients died of metastatic renal cell carcinoma 17 to 47 months (mean 35.5 months) postoperatively, 2 of whom had concomitant local recurrences in the renal remnant. Based on previously reported results of total nephrectomy for renal cell carcinoma with venous involvement and the morbidity associated with renal replacement therapy, we believe that a nephron-sparing operation is a viable option in the management of these patients.

Entities:  

Mesh:

Year:  1990        PMID: 2231924     DOI: 10.1016/s0022-5347(17)39738-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Nephron-sparing surgery for renal cell carcinoma.

Authors:  K H Tsui; A van Ophoven; O Shvarts; A Belldegrun
Journal:  Rev Urol       Date:  1999

Review 2.  Long-term outcomes of the surgical management of renal cell carcinoma.

Authors:  John S Lam; Arie S Belldegrun; Allan J Pantuck
Journal:  World J Urol       Date:  2006-02-15       Impact factor: 4.226

Review 3.  Open partial nephrectomy for the treatment of renal cell carcinoma.

Authors:  Brian Shuch; John S Lam; Arie S Belldegrun
Journal:  Curr Urol Rep       Date:  2006-01       Impact factor: 2.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.